Dr Chris Boyle > Sidley Austin LLP > London, England > Lawyer Profile
Sidley Austin LLP Offices
70 St Mary Axe
London
EC3A 8BE
England
- Firm Profile
- Go to...
Dr Chris Boyle
Position
Counsel
Career
DR. CHRIS BOYLE is a life sciences lawyer and qualified veterinarian whose practice spans UK and EU regulatory, disputes and transactional work, and he serves clients in the drug, device, food, chemical and animal health industries, often in multi-jurisdictional projects. Chris brings deep industry and scientific knowledge from his experience as a veterinarian and over a decade in life-sciences law. Chris’ regulatory practice focusses on solving complex regulatory issues where there is high regulatory or compliance risk or where valuable regulatory IP rights are at stake. In his litigation practice he assists clients to challenge regulatory decisions, protect reputation and enforce IP exclusivities. In his transactional practice, Chris supports complex life sciences corporate transactions and private equity deals by providing valuable legal and industry insights, and specialist due diligence.
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
(Next Generation Partners)Known for its ability to handle regulatory issues relating to orphan drugs, cell and gene therapy products, and digital health tools, Sidley Austin LLP is additionally active across areas including product liability, cybersecurity, M&A, and collaborations and licencing. Maria Isabel Manley leads the life sciences team for Sidley’s office in London and frequently brings her knowledge of EU and UK regulatory and competition law to bear when representing clients before regulatory authorities. Robert Darwin is a key contact for global life sciences and healthcare corporations looking to do transactions. James Wood is well-placed to handle M&A work in the sector. Solicitor advocate Chris Boyle, and Zina Chatzidimitriadou, who excels in market access strategy matters, are further recommended.
Lawyer Rankings
- Next Generation Partners London > Industry focus > Life sciences and healthcare
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
Firm Rankings
- Finance > Debt capital markets
- Finance > Derivatives and structured products
- Industry focus > Life sciences and healthcare
- Finance > Securitisation
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- TMT (technology, media and telecoms) > Fintech: regulatory
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Insurance > Insurance: corporate and regulatory
- Corporate and commercial > Private equity: transactions – high-value deals (£500m+)
- Dispute resolution > Banking litigation: investment and retail
- Real estate > Commercial property: investment
- Corporate and commercial > Corporate tax
- Risk advisory > Data protection, privacy and cybersecurity
- Corporate and commercial > Financial services: contentious
- Corporate and commercial > Financial services: non-contentious/regulatory
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Dispute resolution > Commercial litigation: premium
- Investment fund formation and management > Private funds
- Corporate and commercial > EU and competition
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Real estate > Property finance